Metric Finance
LearnFAQ
LearnFAQ

Learn / MNKD

NASDAQ: MNKD

Mannkind (MNKD) stock, explained like you're 5

Mannkind trades on the Nasdaq under the ticker MNKD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

Ticker
MNKD
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.1 billion dollars

Is Mannkind a small, medium or large cap company?

No. Mannkind is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Mannkind makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves MNKD stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • MNKD Stock Rises Premarket As FDA Verdict Nears Retail Optimism Builds (Stocktwits)
  • Does MannKind (MNKD) Have a Differentiated Cardiorenal Strategy or Just Incremental Delivery Innovation? (Yahoo Finance)
  • Furoscix Data Could Shape The Case For MannKind Stock (Simply Wall Street)
  • Is MannKind a Stock to Sell After Its CEO Let Go of 363,200 Shares? (The Motley Fool)
  • Shares valued at $128,478 are proposed for sale by MannKind (MNKD) director Steven Binder. (Stock Titan)

Follow MNKD in your daily brief

Each trading day at 5 PM ET we post what happened to Mannkind and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow MNKD

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Mannkind stock

What does Mannkind do?

Mannkind trades on the Nasdaq under the ticker MNKD. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.

What is the ticker symbol for Mannkind?

Mannkind trades under the ticker MNKD on the Nasdaq.

What is Mannkind's market cap?

Mannkind is a small cap stock with a market cap of about 1.1 billion dollars.

How does Mannkind make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves MNKD stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow MNKD stock every day?

Add MNKD to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow MNKD daily

A free brief on Mannkind and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare MNKD: MNKD vs NVS, MNKD vs AZN, MNKD vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed